Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Invested Capital (2022 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Return on Invested Capital for 4 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 19.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04% through Dec 2025, down 19.0% year-over-year, with the annual reading at 0.04% for FY2025, 21.0% down from the prior year.
  • Return on Invested Capital hit 0.04% in Q4 2025 for Harmony Biosciences Holdings, down from 0.22% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.62% in Q3 2022 to a low of 0.04% in Q4 2025.
  • Historically, Return on Invested Capital has averaged 0.32% across 4 years, with a median of 0.26% in 2023.
  • Biggest YoY gain for Return on Invested Capital was 5bps in 2023; the steepest drop was -29bps in 2023.
  • Year by year, Return on Invested Capital stood at 0.56% in 2022, then crashed by -53bps to 0.26% in 2023, then decreased by -14bps to 0.22% in 2024, then tumbled by -83bps to 0.04% in 2025.
  • Business Quant data shows Return on Invested Capital for HRMY at 0.04% in Q4 2025, 0.22% in Q3 2025, and 0.23% in Q2 2025.